Release Notes; Version 20180614
General Notes
The following files will be available as full release files within this version:
- Manufactured Product,
- Non-proprietary Therapeutic Product,
- Therapeutic Moiety,
- Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Product Relationship,
- Special Groupings,
- Coded Attribute, and
- Device Non-proprietary Therapeutic Product.
The 'Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
The “Delta" release contains only those concepts that have been added or changed since the previous release. The type of changes would include; inactivated and changes to any description. Delta files will be provided in a future release.
The scope of this release includes most of the top 250 moieties plus additional content beyond the top 250.
The table below provides the number of concepts within each CCDD file for this release.
June 2018 CCDD Files | Number of Concepts | Types of Changes in this release |
|---|---|---|
| Therapeutic Moiety Full Release | 535 | 47 additions |
| Non-proprietary Therapeutic Product Full Release | 1990 | 161 additions;
3 status change from Active to Inactive 1 status change from Active to Deprec (deprecated), giving 1 new deprecated concept (9000819), (see below) 8 status date changes to deprecated concepts; 10 other status date changes (no change in status) |
| Manufactured Product Full Release | 7359 | 337 additions Formal name changes made:
34 status changes from Active to Inactive 35 status date changes (no change in status) 1 new deprecated concept (see below) 154 concepts have had their mp_code updated from 70xxxx to 777xxxx as agreed through Medication Management |
Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Moiety Relationship | 7358 | Includes concept additions and formal name and mp_code changes as above Deprecated concepts have been excluded. |
| Device Non-proprietary Therapeutic Product | 3 | no change |
| Special Groupings | 1434 | 4 additions Includes concept additions and formal name and mp_code changes as above |
| Coded Attributes | 7 | no change |
NTP Specific Comments
The following concept was deprecated in the June release and re-authored as represented below:
| NTP code May release | NTP formal name May release | NTP code June release | NTP formal name June release |
|---|---|---|---|
| 9000819 | ibuprofen 40 mg per mL oral suspension | 9012636 | ibuprofen 40 mg per mL oral drops |
Manufactured Product Specific Comments
the following MP code and formal name have been deprecated in the June release and replaced as represented below:
| MP code May release | MP formal name May release | MP code June release | MP formal name June release |
|---|---|---|---|
| 02212188 | IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) GLAXOSMITHKLINE INC | 77700586 | IMITREX (sumatriptan (sumatriptan succinate) 6 mg per 0.5 mL solution for injection syringe) GLAXOSMITHKLINE INC |
The following table provides the MPs that have changed in the June release as a result of a NTP name change.
| June Release | May Release | ||
| 00030619 | SOLU-CORTEF 250 MG ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 250 mg powder for solution for injection with diluent solution per vial) PFIZER CANADA INC | 00030619 | SOLU-CORTEF 250 MG ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 250 mg per vial powder for solution for injection) PFIZER CANADA INC |
| 00030600 | SOLU-CORTEF 100 MG ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 100 mg per vial powder for solution for injection) PFIZER CANADA INC | 00030600 | SOLU-CORTEF 100 MG ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 100 mg per vial powder for solution for injection) PFIZER CANADA INC |
| 00030635 | SOLU-CORTEF 1 GM ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 1 g per vial powder for solution for injection) PFIZER CANADA INC | 00030635 | SOLU-CORTEF 1 GM ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 1 g per vial powder for solution for injection) PFIZER CANADA INC |
| 02238626 | INFANT'S MOTRIN SUSPENSION DROPS (ibuprofen 40 mg per mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 02238626 | INFANT'S MOTRIN SUSPENSION DROPS (ibuprofen 40 mg per mL oral suspension) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
| 02328445 | ADVIL PEDIATRIC DROPS FEVER FROM COLDS OR FLU (ibuprofen 40 mg per mL oral suspension) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA INC | 02328445 | ADVIL PEDIATRIC DROPS FEVER FROM COLDS OR FLU (ibuprofen 40 mg per mL oral suspension) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA INC |
| 02242522 | ADVIL PEDIATRIC DROPS (ibuprofen 40 mg per mL oral suspension) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA INC | 02242522 | ADVIL PEDIATRIC DROPS (ibuprofen 40 mg per mL oral suspension) PFIZER CONSUMER HEALTHCARE A DIVISION OF PFIZER CANADA INC |
| 00030627 | SOLU-CORTEF 500 MG ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 500 mg per vial powder for solution for injection) PFIZER CANADA INC | 00030627 | SOLU-CORTEF 500 MG ACT-O-VIAL (hydrocortisone (hydrocortisone sodium succinate) 500 mg per vial powder for solution for injection) PFIZER CANADA INC |
It is the intent of the CCDD formal names to always be unique. However, in this release there remains a few Manufactured Product concept formal names that did not generate uniquely following the CCDD Manufactured Product naming pattern as documented in the MP Formal Name Pattern section of the Editorial Guidelines. See below for an example:
02028174 | ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC |
02025337 | ACETAMINOPHEN, CAFFEINE & CODEINE (acetaminophen 300 mg and caffeine 15 mg and codeine phosphate 8 mg oral tablet) PHARMASCIENCE INC |
This lack of unique formal names for the Manufactured Product will continue to be addressed via a change made to the Health Canada Drug Database over the course of the next couple of months.
Terminology Gateway Specific Comments
A link to the Release notes on this page has been added to the Gateway CCDD files. Users may use the "Change Logs" available when viewing each individual file on the Gateway. The change logs identify the additions and changes to a code or formal name only. If there has been a change to a status or status date, it will not appear in the change log at this time.
Questions, Concerns, Changes
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]
Please note that to access InfoCentral, you must have an Infoway login. If you have any questions about any of our standards or products, please contact the Infodesk Desk at:
Toll Free #: 1-877-595-3417 or 416-595-3417
E-mail: [email protected]
v